By Scientia Professor Vlado Perkovic

Journal articles

Gallagher MP; Webster AC; Jardine MJ; Perkovic V; Cass A; Eris JM, 2008, 'TWENTY YEAR CANCER OUTCOMES OF A RANDOMISED TRIAL OF IMMUNOSUPPRESSION IN KIDNEY TRANSPLANT RECIPIENTS: RESULTS OF THE AUSTRALIAN MULTICENTRE TRIAL OF CYCLOSPORINE WITHDRAWAL', Transplantation, 86, pp. 102 - 102, http://dx.doi.org/10.1097/01.tp.0000332497.13679.a7

White SL; McGeechan K; Jones M; Cass A; Chadban SJ; Polkinghorne KR; Perkovic V; Roderick PJ, 2008, 'Socioeconomic disadvantage and kidney disease in the United States, Australia, and Thailand', American Journal of Public Health, 98, pp. 1306 - 1313, http://dx.doi.org/10.2105/AJPH.2007.116020

Turnbull F, 2008, 'Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger people: Meta-analysis of randomised trials', BMJ, 336, pp. 1121 - 1123, http://dx.doi.org/10.1136/bmj.39548.738368.BE

Strippoli GFM; Navaneethan SD; Johnson DW; Perkovic V; Pellegrini F; Nicolucci A; Craig JC, 2008, 'Effects of statins in patients with chronic kidney disease: Meta-analysis and meta-regression of randomised controlled trials', BMJ, 336, pp. 645 - 651, http://dx.doi.org/10.1136/bmj.39472.580984.AE

Perkovic V; Cass A; Patel AA; Suriyawongpaisal P; Barzi F; Chadban S; MacMahon S; Neal B, 2008, 'High prevalence of chronic kidney disease in Thailand', Kidney International, 73, pp. 473 - 479, http://dx.doi.org/10.1038/sj.ki.5002701

Ninomiya T; Perkovic V; Gallagher M; Jardine M; Cass A; Arima H; Anderson C; Neal B; Woodward M; Omae T; MacMahon S; Chalmers J, 2008, 'Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial', Kidney International, 73, pp. 963 - 970, http://dx.doi.org/10.1038/ki.2008.5

Perkovic V; Huxley R; Wu Y; Prabhakaran D; MacMahon S, 2007, 'The burden of blood pressure-related disease: A neglected priority for global health', Hypertension, 50, pp. 991 - 997, http://dx.doi.org/10.1161/HYPERTENSIONAHA.107.095497

Chalmers J; Kengne AP; Joshi R; Perkovic V; Patel A, 2007, 'New insights from ADVANCE.', Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 25 Suppl 1

Agodoa L; Anderson C; Asseibergs F; Baigent C; Black H; Brenner B; Brown M; Bulpitt C; Byington R; Chalmers J; Collins R; Cutler J; Dahlof B; Davis B; De Zeeuw D; Dens J; Estacio R; Fagard R; Fox K; Fukui T; Hansson L; Holman R; Hunsicker L; Imai Y; Ishii M; Kanno Y; Kostis J; Kuramoto K; Lewis E; Lièvre M; Lindholm LH; Liu L; Lubsen J; Lueders S; MacMahon S; Malacco E; Mancia G; Matsuzaki M; Neal B; Nissen S; Ohkubo T; Ogihara T; Pepine C; Pfeffer M; Pitt B; Poole-Wilson P; Rahman M; Remme W; Remuzzi G; Rodgers A; Ruggenenti P; Saruta T; Schrader J; Schrier R; Sever P; Sleight P; Staessen J; Teo K; Viberti G; Wang J; Whelton P; Wing L; Yui Y; Yusuf S; Zanchetti A; Turnbull F; Kostis J; Algert C; Woodward M; Zanchetti A, 2007, 'Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system', Journal of Hypertension, 25, pp. 951 - 958, http://dx.doi.org/10.1097/HJH.0b013e3280bad9b4

Glasziou P; Alexander J; Beller E; Clarke P; Chalmers J; MacMahon S; Cooper M; Ferrannini E; Grobbee D; Hamet P; Harrap S; Heller S; Lisheng L; Mancia G; Marre M; Mogensen C; Neal B; Yu Pan C; Patel A; Poulter N; Rodgers A; William B; Woodward M; Collins R; Holman R; Sleight P; Adams M; Branley M; Fulcher G; Jenkins B; Louis D; Lou W; Lowe H; McCormack A; Mitchell P; Ong S; Pollock C; Watson J; Wong T; Allen S; Bompoint S; Carreras A; Chen T; Flynn S; Gibbo S; Han D; Hough S; Jayne K; Joshi R; Kengne AP; Linn J; Monaghan H; Ng R; Perkovic V; Regaglia J; Schmidt M; Xin D; Yufang B; Holloway T; Gray B; Milne A; Adderkin A; Guertin MR; de Guise D; Liyuan M; Reid J; Subramaniam R; Wen W; Williamson K, 2007, 'Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial', Health and Quality of Life Outcomes, 5, pp. 21, http://dx.doi.org/10.1186/1477-7525-5-21

Perkovic V; Ninomiya T; Arima H; Gallagher M; Jardine M; Cass A; Neal B; MacMahon S; Chalmers J, 2007, 'Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: Data from the PROGRESS study', Journal of the American Society of Nephrology, 18, pp. 2766 - 2772, http://dx.doi.org/10.1681/ASN.2007020256

Zentner D; Chan W; Perkovic V; Grigg L; Hunt D, 2007, 'Outcomes of Aortic Stenosis—A Comparison of Dialysis Patients Versus Controls', Heart, Lung and Circulation, 16, pp. S79 - S79, http://dx.doi.org/10.1016/j.hlc.2007.06.203

Gallagher M; Perkovic V; Chalmers J, 2006, 'Diuretics: A modern day treatment option? (Review article)', Nephrology, 11, pp. 419 - 427, http://dx.doi.org/10.1111/j.1440-1797.2006.00598.x

Chalmers J; Perkovic V; Joshi R; Patel A, 2006, 'ADVANCE: Breaking new ground in type 2 diabetes', Journal of Hypertension, 24, pp. S22 - S28, http://dx.doi.org/10.1097/01.hjh.0000240043.50838.28

Chalmers J; Perkovic V; Joshi RC; Patel A, 2006, 'ADVANCE : breaking new ground in type 2 diabetes', Journal of Hypertension (Supplement), 24, pp. S22 - S28

Suranyi MG, 2006, 'ADVANCE: lessons from the run-in phase of a large study in type 2 diabetes.', Blood Pressure, 15, pp. 340 - 346

Kerr P; Perkovic V; Petrie J; Agar J; Disney A, 2005, 'The CARI guidelines. Dialysis adequacy (HD) guidelines.', Nephrology Carlton Vic, 10 Suppl 4, pp. S61 - S80

Packham DK; Perkovic V; Savige J; Broome MRA, 2005, 'Hematuria in thin basement membrane nephropathy', Seminars in Nephrology, 25, pp. 146 - 148, http://dx.doi.org/10.1016/j.semnephrol.2005.01.005

, 2005, 'Blood urea sampling methods', Nephrology, 10, http://dx.doi.org/10.1111/j.1440-1797.2005.00464_2.x

, 2005, 'Dialysis membranes', Nephrology, 10, http://dx.doi.org/10.1111/j.1440-1797.2005.00464_3.x

, 2005, 'Duration and frequency of haemodialysis therapy', Nephrology, 10, http://dx.doi.org/10.1111/j.1440-1797.2005.00464_4.x

, 2005, 'Haemodialysis anticoagulation and adequacy', Nephrology, 10, http://dx.doi.org/10.1111/j.1440-1797.2005.00464_6.x

, 2005, 'Water quality for haemodialysis', Nephrology, 10, http://dx.doi.org/10.1111/j.1440-1797.2005.00464_5.x

Perkovic V; Hewitson TD; Kelynack KJ; Martic M; Tait MG; Becker GJ, 2003, 'Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells', Kidney and Blood Pressure Research, 26, pp. 27 - 33, http://dx.doi.org/10.1159/000069761

Perkovic V; Hunt D; Griffin SV; du Plessis M; Becker GJ, 2003, 'Accelerated progression of calcific aortic stenosis in dialysis patients.', Nephron Clinical Practice, 94, pp. c40 - c45, http://dx.doi.org/10.1159/000071280

Perkovic V; Thomson KR; Becker GJ, 2002, 'Factors affecting outcome after percutaneous renal artery stent insertion', Journal of Nephrology, 15, pp. 649 - 654

Perkovic V; Hunt D; Griffin SV; Plessis MD; Becker GJ, 2002, 'ACCELERATED PROGRESSION OF CALCIFIC AORTIC STENOSIS IN DIALYSIS PATIENTS', Nephrology, 7, pp. A106 - A106, http://dx.doi.org/10.1046/j.1440-1797.2002.00007-1-106.x

Perkovic V; Thomson KR; Becker GJ, 2002, 'LONG TERM OUTCOMES OF STENT INSERTION FOR RENAL ARTERY STENOSIS', Nephrology, 7, http://dx.doi.org/10.1046/j.1440-1797.2002.00007-1-7.x

Kelynack KJ; Hewitson TD; Martic M; Perkovic V; McTaggart S; Becker GJ, 2002, 'LOVASTATIN DOWNREGULATES RENAL MYOFIBROBLAST FUNCTION IN VITRO', Nephrology, 7, http://dx.doi.org/10.1046/j.1440-1797.2002.00007-1-2.x

Perkovic V; Hewitson TD; Kelynack KJ; Martic M; Tait MG; Becker GJ, 2002, 'PARATHYROID HORMONE HAS A PROSCLEROTIC EFFECT ON VASCULAR SMOOTH MUSCLE CELLS', Nephrology, 7, http://dx.doi.org/10.1046/j.1440-1797.2002.00007-1-69.x

Becker GJ; Perkovic V; Hewitson TD, 2001, 'Pharmacological intervention in renal fibrosis and vascular sclerosis', Journal of Nephrology, 14, pp. 332 - 339

Perkovic V; Thomson KR; Mitchell PJ; Gibson RN; Atkinson N; Field PL; Becker GJ, 2001, 'Treatment of renovascular disease with percutaneous stent insertion: Long-term outcomes', Australasian Radiology, 45, pp. 438 - 443, http://dx.doi.org/10.1046/j.1440-1673.2001.00953.x

Perkovic V; Came NA; Grigg AP; Becker GJ, 1999, 'Haemolytic uraemic syndrome and prostatic cancer', Australian and New Zealand Journal of Medicine, 29, pp. 383 - 384, http://dx.doi.org/10.1111/j.1445-5994.1999.tb00730.x

Conference Papers

Mann JFE; Tuttle KR; Pratley RE; Mahaffey KW; Arici M; Belmar N; Bonefeld K; Chernin G; Correa-Rotter R; Gillard P; Hadjadj S; Idorn T; Ji L; Linder M; Schmieder RE; Shamkhalova M; Sriwijitkamol A; Perkovic V; Rossing P, 2025, 'Impact of Semaglutide on Kidney, Cardiovascular, and Mortality Outcomes by Baseline BMI and Weight Loss in People with T2D and CKD-Data from the FLOW Trial', in DIABETES, AMER DIABETES ASSOC, IL, Chicago, presented at 85th Scientific Sessions of the American-Diabetes-Association (ADA), IL, Chicago, 20 June 2025 - 23 June 2025, http://dx.doi.org/10.2337/db25-1971-LB

Perkovic V; Barratt J; Carroll K; Fajardo C; Hafkin J; Lafayette R; Liew A; Shah L; Suzuki Y; Tesar V; Trimarchi H; Wong MG; Xia J; Zhan H; Rizk D, 2025, 'PATIENT BASELINE CHARACTERISTICS IN THE ONGOING PHASE 3 VISIONARY TRIAL: A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF SIBEPRENLIMAB FOR IMMUNOGLOBULIN A NEPHROPATHY', in AMERICAN JOURNAL OF KIDNEY DISEASES, W B SAUNDERS CO-ELSEVIER INC

Tuttle K; Bakris G; Bang C; Bax W; Belmar N; Brown P; Cherney D; Chernin G; Lim SK; Mann J; Perkovic V; Pratley R; Ridker P; Rossing P; Schmieder R; Shamkhalova MS; Sreenivasamurthy L; Mahaffey K, 2024, 'Benefits of Semaglutide on Chronic Kidney Disease Outcomes by Cardiovascular Status or Risk in the FLOW trial', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, pp. E746 - E746, presented at American-Heart-Association Resuscitation Science Symposium, IL, Chicago, 16 November 2024 - 18 November 2024

Rossing P; Bakris GL; Perkovic V; Pratley R; Tuttle K; Mahaffey K; Idorn T; Nazal NB; Bosch-Traberg H; Rasmussen S; Busch RS; Schmieder R; Gillard P; Mann J, 2024, 'Kidney, cardiovascular and all-cause mortality outcomes of semaglutide with and without baseline MRA use in type 2 diabetes and CKD: a FLOW trial analysis', in DIABETOLOGIA, SPRINGER, SPAIN, Madrid, pp. S519 - S519, presented at 60th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), SPAIN, Madrid, 09 September 2024 - 13 September 2024

Perkovic V; Barratt J; Radhakrishnan J; Rizk D; Trimarchi H; Khawaja Z; Leiske J; Sorensen B; King A; Jones-Burton C; Campbell K, 2023, 'A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF BION-1301 IN ADULTS WITH IGA NEPHROPATHY', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, ITALY, Milan, pp. I398 - I399, presented at 60th ERA Congress, ITALY, Milan, 15 June 2023 - 18 June 2023

Singh AK; Claggett BL; Perkovic V; Hiemstra T; Khavandi K; Lukas MA; Ranganathan P; Shannon JB; van Adelsberg J; Solomon S, 2023, 'HEART FAILURE IN ASCEND-ND AND ASCEND-D', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, ITALY, Milan, pp. I453 - I455, presented at 60th ERA Congress, ITALY, Milan, 15 June 2023 - 18 June 2023

Heerspink HJ; Agarwal R; Bakris GL; Cherney D; Lam CSP; Neuen BL; Tuttle KR; Wanner C; Brinker MD; Dizayee S; Kolkhof P; Schloemer P; Vesterinen PH; Perkovic V, 2023, 'Design and Baseline Characteristics of the FIND-CKD Trial: Efficacy of Finerenone on Kidney Disease Progression in People with Non-Diabetic CKD', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. 678 - 678

Tangri N; Ferguson T; Bamforth RJ; Arnott CG; Mahaffey K; Heerspink HJ; Perkovic V; Neuen BL, 2023, 'External Validation of a Machine Learning Model for Progression of CKD in the CREDENCE and CANVAS Trials', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. 418 - 419

Ha JT; Hiremath S; Jun M; Palmer SC; Wheeler DC; Coyne DW; Perkovic V; Badve SV, 2023, 'LONG-TERM SAFETY OF HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITORS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS', in NEPHROLOGY, WILEY, pp. 12 - 12

Ha J; Hiremath S; Jun M; Palmer S; Wheeler DC; Coyne DW; Perkovic V; Badve S, 2023, 'Long-Term Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in CKD: A Systematic Review and Meta-Analysis of Randomized Trials', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. 367 - 367

Jun M; Wick J; Neuen BL; Kotwal SS; Badve S; Chalmers JP; Jardine M; Perkovic V; Gallagher MP; Ronksley PE, 2023, 'The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. 373 - 373

Sharma AA; Neuen BL; Fletcher RA; Slee A; Rapattoni W; Ang FG; Arnott C; Levin A; Verma S; Perkovic V; Mahaffey KW, 2023, 'Timing of statistical benefit of canagliflozin in patients with type 2 diabetes for cardiovascular and heart failure outcomes: insights from the CANVAS Program and CREDENCE trial', in EUROPEAN JOURNAL OF HEART FAILURE, WILEY, pp. 177 - 178

Kolkailah AA; Marx N; Rosenstock J; Johansen OE; Cooper ME; Alexander JH; Toto R; Wanner C; Espeland MA; Mattheus M; Schnaidt S; Perkovic V; Gollop ND; McGuire DK, 2022, 'Assessment Of Associations Between Hypoglycemia And Cardiovascular Outcomes In The Randomized CARMELINA And CAROLINA Trials Of The Antihyperglycemic Medication Linagliptin', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium, IL, Chicago, 05 November 2022 - 06 November 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000890856904142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Koshino A; Schechter M; Sen T; Neuen BL; Arnott C; Neal B; Perkovic V; Ridker PM; Tuttle KR; Hansen MK; Heerspink HJL, 2022, 'Interleukin-6 and cardiovascular outcome in patients with type 2 diabetes: new insights from CANVAS', in DIABETOLOGIA, SPRINGER, SWEDEN, Stockholm, pp. S282 - S282, presented at 58th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), SWEDEN, Stockholm, 19 September 2022 - 23 September 2022

Perkovic V; Baeres F; Bakris G; Bosch-Traberg H; Idorn T; Mahaffey K; Mann J; Mersebach H; Rossing P; Tuttle K; Pratley R, 2022, 'BASELINE CHARACTERISTICS OF THE FLOW TRIAL POPULATION: KIDNEY OUTCOMES TRIAL WITH ONCE-WEEKLY SEMAGLUTIDE IN PEOPLE WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, FRANCE, Paris, pp. I893 - I894, presented at 59th Congress of the European-Renal-Association (ERA), FRANCE, Paris, 19 May 2022 - 22 May 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000813350704181&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Perkovic V; Tuttle KR; Pergola PE; Mahaffey KW; Patel UD; Ishida JH; Chen F; Crans G; Kustra R; Trivedi M; Heerspink HJL; Rossing P; Kashihara N; Chertow G, 2022, 'A Phase 2b Randomized Controlled Trial of Selonsertib in Moderate to Severe Diabetic Kidney Disease (MOSAIC)', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. 28 - 28

Rizk D; Perkovic V; Lafayette RA; Trimarchi H; Barratt J; Carroll K; Tesar V; Zhang H; Suzuki Y; Liew A; Wong MG; Leslie BR; Mathur M; Hafkin J, 2022, 'A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Patients With IgA Nephropathy', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. 799 - 799

Back to profile page